EYENOVIA, INC. (EYEN)
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Address
295 MADISON AVENUE,
NEW YORK, NY 10017
Founded
2014
Number of Employees
57
Website
http://www.eyenovia.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)